• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT
Click for more information
6.67% 4.2¢

SYNTARA LIMITED

Market Cap $57.67M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT
Syntara the science explained
2
04/11/24 95 35K
04/11/24 Last post  pinch2020 Comments Created with Sketch.  95  Views Created with Sketch.  35K 
SNT
Ann: Presentation for September Quarterly Shareholder Update 		04/11/24 8 2.8K
04/11/24 Last post  NZ Trader Comments Created with Sketch.  8  Views Created with Sketch.  2.8K 
SNT
Ann: Quarterly Activities Report 		30/10/24 5 1.3K
TRENDING NEWS

React to US elections with Plus500!

Read More   right-arrow Created with Sketch.
NEWS
05 Nov 2024
30/10/24 Last post  newB Comments Created with Sketch.  5  Views Created with Sketch.  1.3K 
SNT
Ann: Quarterly Appendix 4C Cash Flow Report 		30/10/24 0 207
30/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  207 
SNT
Ann: Phase 2 blood cancer trial fully recruited 		30/10/24 30 9.9K
30/10/24 Last post  NZ Trader Comments Created with Sketch.  30  Views Created with Sketch.  9.9K 
SNT
Ann: Appendix 4C quarterly webinar 		29/10/24 0 292
29/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  292 
SNT
Chart 		29/10/24 11 4.3K
29/10/24 Last post  pinch2020 Comments Created with Sketch.  11  Views Created with Sketch.  4.3K 
SNT
Ann: Receipt of R&D Tax Incentive 		28/10/24 6 1.5K
28/10/24 Last post  pinch2020 Comments Created with Sketch.  6  Views Created with Sketch.  1.5K 

See All Discussions arrow Created with Sketch.

Timeline

Presentation for September Quarterly Shareholder Update
30 Oct 08:50
 
Quarterly Activities Report
30 Oct 08:29
 
Quarterly Appendix 4C Cash Flow Report
30 Oct 08:27
 
Appendix 4C quarterly webinar
29 Oct 15:26
 
Receipt of R&D Tax Incentive
28 Oct 10:09
 
Notice of Annual General Meeting/Proxy Form
25 Oct 09:12
 
View More arrow Created with Sketch.

Featured News

NEWS Ellison slapped with $20M sanction from MinRes but will stay on as leader – for now
right-arrow Created with Sketch.
NEWS PYC Therapeutics moves into final stage of child blindness study
right-arrow Created with Sketch.
NEWS Domino's Don Meij steps down after 22 years as CEO
right-arrow Created with Sketch.
NEWS Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings
right-arrow Created with Sketch.
NEWS Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate
right-arrow Created with Sketch.
NEWS RBA holds rates as ALP election campaigning kicks off – expect more political focus
right-arrow Created with Sketch.
(20min delay)
Last
4.2¢ 		Change
-0.003(6.67%) 		Mkt cap ! $57.67M
Open High Low Value Volume
4.4¢ 4.5¢ 4.2¢ $37.11K 834.3K

Buyers (Bids)

No. Vol. Price($)
3 244513 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 220000 1
View Market Depth
Last trade - 16.10pm 05/11/2024 (20 minute delay) ?
Last
4.3¢ 		  Change
-0.003 ( 0.23 %)
Open High Low Volume
4.6¢ 4.6¢ 4.2¢ 273190
Last updated 15.59pm 05/11/2024 ?
SNT (ASX) Chart

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Let’s get straight to the point: of all the smallcaps in the Telecommunications index, The Market Ltd could be one of the most overlooked.
Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate Harvey Norman has flagged it may appeal a Federal Court decision that favoured with ASIC's view the retailer owes penalties.
Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings Australian bank Judo Capital Holdings (ASX:JDO), best known for its finance and credit for small and medium-sized businesses, is Wealth Within chief analyst Dale Gillham and senior analyst Fil Tortevski@s HotCopper Hot Stock tip this week.Judo Capital has surged up 106.59% over the last 12 months...
RBA holds rates as ALP election campaigning kicks off – expect more political focus The Reserve Bank of Australia (RBA) has acted in line with wide-spread expectations and kept interest rates on hold at 4.35%.
Palladium's the newest geopolitical hot commodity. But ASX exposure is limited On October 24, the USA reportedly approached its G7 counterparts and proposed a ban on Russian titanium, and, palladium.

Featured News

NEWS Ellison slapped with $20M sanction from MinRes but will stay on as leader – for now
right-arrow Created with Sketch.
NEWS Domino's Don Meij steps down after 22 years as CEO
right-arrow Created with Sketch.
NEWS Patronus receives mining approval for Fountain Head
right-arrow Created with Sketch.
NEWS Westpac records 3% fall in net profit for FY24
right-arrow Created with Sketch.
NEWS PYC Therapeutics moves into final stage of child blindness study
right-arrow Created with Sketch.
NEWS Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.